NL1008019C2 - Nieuwe formulering voor inhalatie. - Google Patents

Nieuwe formulering voor inhalatie. Download PDF

Info

Publication number
NL1008019C2
NL1008019C2 NL1008019A NL1008019A NL1008019C2 NL 1008019 C2 NL1008019 C2 NL 1008019C2 NL 1008019 A NL1008019 A NL 1008019A NL 1008019 A NL1008019 A NL 1008019A NL 1008019 C2 NL1008019 C2 NL 1008019C2
Authority
NL
Netherlands
Prior art keywords
composition
bulk density
composition according
budenoside
formulation
Prior art date
Application number
NL1008019A
Other languages
English (en)
Dutch (nl)
Other versions
NL1008019A1 (nl
Inventor
Jan Trofast
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20405452&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL1008019(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astra Ab filed Critical Astra Ab
Publication of NL1008019A1 publication Critical patent/NL1008019A1/xx
Application granted granted Critical
Publication of NL1008019C2 publication Critical patent/NL1008019C2/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL1008019A 1997-01-20 1998-01-13 Nieuwe formulering voor inhalatie. NL1008019C2 (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9700133 1997-01-20
SE9700133A SE9700133D0 (sv) 1997-01-20 1997-01-20 New formulation

Publications (2)

Publication Number Publication Date
NL1008019A1 NL1008019A1 (nl) 1998-07-22
NL1008019C2 true NL1008019C2 (nl) 1998-12-16

Family

ID=20405452

Family Applications (1)

Application Number Title Priority Date Filing Date
NL1008019A NL1008019C2 (nl) 1997-01-20 1998-01-13 Nieuwe formulering voor inhalatie.

Country Status (35)

Country Link
US (1) US6027714A (es)
EP (1) EP1019033B1 (es)
JP (1) JP2010059179A (es)
KR (1) KR100528418B1 (es)
CN (1) CN1222282C (es)
AT (1) ATE389390T1 (es)
AU (1) AU726916B2 (es)
BE (1) BE1011400A5 (es)
BR (1) BR9806892A (es)
CA (1) CA2277914C (es)
CZ (1) CZ295083B6 (es)
DE (1) DE69839275T2 (es)
DK (1) DK1019033T3 (es)
EE (1) EE03998B1 (es)
ES (2) ES2302348T3 (es)
FR (1) FR2759908B1 (es)
GR (1) GR1003290B (es)
HK (1) HK1025516A1 (es)
HU (1) HU228312B1 (es)
ID (1) ID22883A (es)
IE (1) IE980024A1 (es)
IL (1) IL130840A (es)
IS (1) IS2563B (es)
NL (1) NL1008019C2 (es)
NO (1) NO327451B1 (es)
NZ (1) NZ336592A (es)
PL (1) PL191569B1 (es)
PT (1) PT1019033E (es)
RU (1) RU2180563C2 (es)
SE (1) SE9700133D0 (es)
SI (1) SI1019033T1 (es)
SK (1) SK283948B6 (es)
TR (1) TR199901691T2 (es)
UA (1) UA57762C2 (es)
WO (1) WO1998031350A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6681768B2 (en) 2001-06-22 2004-01-27 Sofotec Gmbh & Co. Kg Powder formulation disintegrating system and method for dry powder inhalers

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9803770D0 (sv) * 1998-11-05 1998-11-05 Astra Ab Dry powder pharmaceutical formulation
EP1129705A1 (en) 2000-02-17 2001-09-05 Rijksuniversiteit te Groningen Powder formulation for inhalation
GB0008660D0 (en) * 2000-04-07 2000-05-31 Arakis Ltd The treatment of respiratory diseases
GB0012261D0 (en) * 2000-05-19 2000-07-12 Astrazeneca Ab Novel process
FR2809692A1 (fr) 2000-05-31 2001-12-07 Ecia Equip Composants Ind Auto Ensemble de masquage d'un coussin gonflable de securite pour vehicule automobile, procede de fabrication et planche de bord correspondante
US20020141946A1 (en) * 2000-12-29 2002-10-03 Advanced Inhalation Research, Inc. Particles for inhalation having rapid release properties
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US7931022B2 (en) * 2001-10-19 2011-04-26 Respirks, Inc. Method and apparatus for dispensing inhalator medicament
SE0200657D0 (sv) * 2002-03-04 2002-03-04 Astrazeneca Ab Novel Formulation
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
GB0327723D0 (en) * 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
US20070020298A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid
CN100333727C (zh) * 2004-11-25 2007-08-29 天津药业研究院有限公司 布地奈德靶向微丸及其制备方法
ES2493641T3 (es) * 2007-06-28 2014-09-12 Cydex Pharmaceuticals, Inc. Administración nasal de soluciones acuosas de corticosteroides
DE102007049931A1 (de) 2007-10-18 2009-04-23 Pharmatech Gmbh Vorrichtung und Verfahren zur kontinuierlichen Herstellung von sphärischen Pulveragglomeraten
WO2011110852A1 (en) 2010-03-10 2011-09-15 Astrazeneca Ab Polymorphic forms of 6- [2- (4 -cyanophenyl) - 2h - pyrazol - 3 - yl] - 5 -methyl - 3 - oxo - 4 - (trifluoromethyl - phenyl) 3,4-dihydropyrazine-2-carboxylic acid ethylamide
ES2662847T3 (es) 2013-07-01 2018-04-10 Arven Ilac Sanayi Ve Ticaret A.S. Formulaciones novedosas de inhalación
CA3073195A1 (en) 2017-08-15 2019-02-21 Nephron Pharmaceuticals Corporation Aqueous nebulization composition
BR112022004970A2 (pt) 2019-09-24 2022-08-23 Chiesi Farm Spa Formulação de pó seco, processo para preparar uma formulação de pó seco e inalador de pó seco

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2269992A (en) * 1992-08-14 1994-03-02 Rh Ne Poulenc Rorer Limited Powder inhalation formulations
WO1995009616A1 (en) * 1993-10-01 1995-04-13 Astra Aktiebolag Process ii
DE4425255A1 (de) * 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
WO1996009814A1 (en) * 1994-09-29 1996-04-04 Andaris Limited Spray-dried microparticles as therapeutic vehicles
RU2071317C1 (ru) * 1994-12-21 1997-01-10 Александр Григорьевич Чучалин Лекарственный порошкообразный препарат для ингаляций

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1429184A (en) * 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
GB1571629A (en) * 1977-11-30 1980-07-16 Fisons Ltd Pharmaceutical compositions containing beclomethasone dipropionate
CY1492A (en) * 1981-07-08 1990-02-16 Draco Ab Powder inhalator
SE438261B (sv) * 1981-07-08 1985-04-15 Draco Ab Anvendning i dosinhalator av ett perforerat membran
DE3268533D1 (en) * 1981-07-24 1986-02-27 Fisons Plc Inhalation drugs, methods for their production and pharmaceutical formulations containing them
EP0470154B1 (en) * 1989-04-28 1996-06-05 Riker Laboratories, Inc. Dry powder inhalation device
US5176132A (en) * 1989-05-31 1993-01-05 Fisons Plc Medicament inhalation device and formulation
US5192548A (en) * 1990-04-30 1993-03-09 Riker Laboratoires, Inc. Device
SE9100342D0 (sv) * 1991-02-04 1991-02-04 Astra Ab Novel steroid esters
SE9100341D0 (sv) * 1991-02-04 1991-02-04 Astra Ab Novel steroids
SE9302777D0 (sv) * 1993-08-27 1993-08-27 Astra Ab Process for conditioning substances
SE9101090D0 (sv) * 1991-04-11 1991-04-11 Astra Ab Process for conditioning of water-soluble substances
ZA924164B (en) * 1991-06-10 1993-02-24 Schering Corp Non-chlorofluorocarbon aerosol formulations
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
DE69232462T2 (de) * 1991-12-18 2002-10-10 Astrazeneca Ab Formoterol und budesonide enthaltende zusammensetzung
US5355872B1 (en) * 1992-03-04 1998-10-20 John H Riggs Low flow rate nebulizer apparatus and method of nebulization
ATE223704T1 (de) * 1992-10-16 2002-09-15 Nippon Shinyaku Co Ltd Verfahren zur herstellung von wachsmatrizes
EG20677A (en) * 1993-10-01 1999-11-30 Astra Ag Method and an apparatus for micronizing the particle size
US5503869A (en) * 1994-10-21 1996-04-02 Glaxo Wellcome Inc. Process for forming medicament carrier for dry powder inhalator
US5647347A (en) * 1994-10-21 1997-07-15 Glaxo Wellcome Inc. Medicament carrier for dry powder inhalator
US5654007A (en) * 1995-06-07 1997-08-05 Inhale Therapeutic Systems Methods and system for processing dispersible fine powders
SE9603669D0 (sv) * 1996-10-08 1996-10-08 Astra Ab New combination

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2269992A (en) * 1992-08-14 1994-03-02 Rh Ne Poulenc Rorer Limited Powder inhalation formulations
WO1995009616A1 (en) * 1993-10-01 1995-04-13 Astra Aktiebolag Process ii
DE4425255A1 (de) * 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
WO1996009814A1 (en) * 1994-09-29 1996-04-04 Andaris Limited Spray-dried microparticles as therapeutic vehicles
RU2071317C1 (ru) * 1994-12-21 1997-01-10 Александр Григорьевич Чучалин Лекарственный порошкообразный препарат для ингаляций

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 9734, Derwent World Patents Index; AN 97-371238 [34], XP002076334 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6681768B2 (en) 2001-06-22 2004-01-27 Sofotec Gmbh & Co. Kg Powder formulation disintegrating system and method for dry powder inhalers

Also Published As

Publication number Publication date
JP2001509811A (ja) 2001-07-24
FR2759908B1 (fr) 2000-04-21
UA57762C2 (uk) 2003-07-15
ES2302348T3 (es) 2008-07-01
CA2277914C (en) 2006-08-29
NO993537L (no) 1999-09-17
HU228312B1 (en) 2013-03-28
EE03998B1 (et) 2003-04-15
PT1019033E (pt) 2008-05-13
IS5110A (is) 1999-07-06
NL1008019A1 (nl) 1998-07-22
ATE389390T1 (de) 2008-04-15
RU2180563C2 (ru) 2002-03-20
SI1019033T1 (sl) 2008-08-31
EE9900320A (et) 2000-02-15
KR100528418B1 (ko) 2005-11-16
GR1003290B (el) 2000-01-03
NO993537D0 (no) 1999-07-19
IL130840A0 (en) 2001-01-28
DE69839275T2 (de) 2009-04-02
AU726916B2 (en) 2000-11-23
SK283948B6 (sk) 2004-05-04
IS2563B (is) 2009-12-15
CA2277914A1 (en) 1998-07-23
TR199901691T2 (xx) 1999-09-21
JP2010059179A (ja) 2010-03-18
GR980100021A (el) 1998-09-30
JP4512202B2 (ja) 2010-07-28
SE9700133D0 (sv) 1997-01-20
US6027714A (en) 2000-02-22
ID22883A (id) 1999-12-16
CZ295083B6 (cs) 2005-05-18
ES2148059B1 (es) 2001-04-01
SK95799A3 (en) 2000-01-18
NZ336592A (en) 2001-01-26
FR2759908A1 (fr) 1998-08-28
HUP0000841A3 (en) 2001-01-29
WO1998031350A1 (en) 1998-07-23
EP1019033B1 (en) 2008-03-19
CN1222282C (zh) 2005-10-12
CN1243434A (zh) 2000-02-02
NO327451B1 (no) 2009-07-06
BE1011400A5 (fr) 1999-08-03
DE69839275D1 (de) 2008-04-30
PL191569B1 (pl) 2006-06-30
PL334493A1 (en) 2000-02-28
AU5785798A (en) 1998-08-07
BR9806892A (pt) 2000-05-16
HK1025516A1 (en) 2000-11-17
EP1019033A1 (en) 2000-07-19
ES2148059A1 (es) 2000-10-01
IL130840A (en) 2005-03-20
IE980024A1 (en) 1998-10-07
CZ255599A3 (cs) 1999-10-13
DK1019033T3 (da) 2008-06-09
HUP0000841A2 (hu) 2000-10-28
KR20000070186A (ko) 2000-11-25

Similar Documents

Publication Publication Date Title
NL1008019C2 (nl) Nieuwe formulering voor inhalatie.
EP1007017B2 (en) Budesonide / formoterol formulation for inhalation having a poured bulk density of 0.30 to 0.36 g/ml, a process for preparing the formulation and the use thereof
US6199607B1 (en) Formulation for inhalation
NL1008021C2 (nl) Nieuwe formulering voor inhalatie.
NL1008020C2 (nl) Nieuwe formulering voor inhalatie.
US5980949A (en) Formulation for inhalation
JP4512202B6 (ja) ブデソニドを含む０．２８から０．３８ｇ／ＭＬのかさ密度を有する吸入用新規製剤

Legal Events

Date Code Title Description
AD1A A request for search or an international type search has been filed
RD2N Patents in respect of which a decision has been taken or a report has been made (novelty report)

Effective date: 19981006

PD2B A search report has been drawn up
MK Patent expired because of reaching the maximum lifetime of a patent

Effective date: 20180112